Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000791908-16-000111
Filing Date
2016-02-16
Accepted
2016-02-16 17:27:34
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 3984
  Complete submission text file 0000791908-16-000111.txt   5478
Mailing Address 2910 SEVENTH ST BERKELEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARYX THERAPEUTICS,INC. 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
Varian John (Reporting) CIK: 0001416176 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-14710 | Film No.: 161430474